EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis

Baker, 1989, Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas, Science, 244, 217, 10.1126/science.2649981 Eliyahu, 1989, Wild-type p53 can inhibit oncogene-mediated focus formation, Proc Natl Acad Sci U S A, 86, 8763, 10.1073/pnas.86.22.8763 Finlay, 1989, The p53 proto-oncogene can act as a suppressor of transformation, Cell, 57, 1083, 10.1016/0092-8674(89)90045-7 Caron de Fromentel, 1992, TP53 tumor suppressor gene: a model for investigating human mutagenesis, Genes Chromosomes Cancer, 4, 1, 10.1002/gcc.2870040102 Levine, 2009, The first 30 years of p53: growing ever more complex, Nat Rev Cancer, 9, 749, 10.1038/nrc2723 Tanikawa, 2009, Regulation of protein Citrullination through p53/PADI4 network in DNA damage response, Cancer Res, 69, 8761, 10.1158/0008-5472.CAN-09-2280 Tanaka, 2000, A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage, Nature, 404, 42, 10.1038/35003506 Tanikawa, 2003, p53RDL1 regulates p53-dependent apoptosis, Nat Cell Biol, 5, 216, 10.1038/ncb943 Tanikawa, 2009, XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway, Oncogene, 28, 3081, 10.1038/onc.2009.154 Funauchi, 2015, Regulation of iron homeostasis by the p53-ISCU pathway, Sci Rep, 5, 16497, 10.1038/srep16497 Mori, 2016, Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity, Cancer Sci, 107, 298, 10.1111/cas.12881 Oda, 2000, p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53, Cell, 102, 849, 10.1016/S0092-8674(00)00073-8 Koguchi, 2016, Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway, Int J Oncol, 48, 2415, 10.3892/ijo.2016.3456 Tanikawa, 2012, CLCA2 as a p53-inducible senescence mediator, Neoplasia, 14, 141, 10.1593/neo.111700 Kazazic, 2009, Epsin 1 is involved in recruitment of ubiquitinated EGF receptors into clathrin-coated pits, Traffic, 10, 235, 10.1111/j.1600-0854.2008.00858.x Chen, 2011, Adaptor protein complex-2 (AP-2) and Epsin-1 mediate protease-activated receptor-1 internalization via phosphorylation- and ubiquitination-dependent sorting signals, J Biol Chem, 286, 40760, 10.1074/jbc.M111.299776 Chen, 2009, Embryonic arrest at midgestation and disruption of Notch signaling produced by the absence of both Epsin 1 and Epsin 2 in mice, Proc Natl Acad Sci U S A, 106, 13838, 10.1073/pnas.0907008106 Tessneer, 2013, Endocytic adaptor protein Epsin is elevated in prostate cancer and required for cancer progression, ISRN Oncol, 2013, 420597 Pasula, 2012, Endothelial Epsin deficiency decreases tumor growth by enhancing VEGF signaling, J Clin Invest, 122, 4424, 10.1172/JCI64537 Ko, 2010, Selective high-level expression of Epsin 3 in gastric parietal cells, where it is localized at endocytic sites of apical canaliculi, Proc Natl Acad Sci U S A, 107, 21511, 10.1073/pnas.1016390107 Spradling, 2001, Epsin 3 is a novel extracellular matrix-induced transcript specific to wounded epithelia, J Biol Chem, 276, 29257, 10.1074/jbc.M101663200 el- Deiry, 1992, Definition of a consensus binding site for p53, Nat Genet, 1, 45, 10.1038/ng0492-45 Smeenk, 2011, Role of p53 serine 46 in p53 target gene regulation, PLoS One, 6, e17574, 10.1371/journal.pone.0017574 Gonzales, 2009, Large-scale proteomics and phosphoproteomics of urinary exosomes, J Am Soc Nephrol, 20, 363, 10.1681/ASN.2008040406 Drake, 2000, Epsin binds to clathrin by associating directly with the clathrin-terminal domain. Evidence for cooperative binding through two discrete sites, J Biol Chem, 275, 6479, 10.1074/jbc.275.9.6479 Rosenthal, 1999, The epsins define a family of proteins that interact with components of the clathrin coat and contain a new protein module, J Biol Chem, 274, 33959, 10.1074/jbc.274.48.33959 Enari, 2006, Requirement of clathrin heavy chain for p53-mediated transcription, Genes Dev, 20, 1087, 10.1101/gad.1381906 Cancer Genome Atlas Research N, 2014, Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 513, 202, 10.1038/nature13480 Haupt, 2003, Apoptosis - the p53 network, J Cell Sci, 116, 4077, 10.1242/jcs.00739 Bar-Shavit, 2011, PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway, IUBMB Life, 63, 397, 10.1002/iub.452 Booden, 2004, Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion, Mol Cell Biol, 24, 1990, 10.1128/MCB.24.5.1990-1999.2004 Kakiuchi, 2014, Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma, Nat Genet, 46, 583, 10.1038/ng.2984 Wang, 2014, Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer, Nat Genet, 46, 573, 10.1038/ng.2983 Lin, 2015, Gene mutations in gastric cancer: a review of recent next-generation sequencing studies, Tumour Biol, 36, 7385, 10.1007/s13277-015-4002-1 Tsukada, 1993, Enhanced proliferative potential in culture of cells from p53-deficient mice, Oncogene, 8, 3313 Malfertheiner, 2012, Management of Helicobacter pylori infection--the Maastricht IV/Florence Consensus Report, Gut, 61, 646, 10.1136/gutjnl-2012-302084